XML 27 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock
Lexam VG Gold
Common Stock
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Flow Through Common Shares
Lexam VG Gold
Total
Balance at Dec. 31, 2015   $ 1,359,144 $ (825) $ (940,027)     $ 418,292
Balance (in shares) at Dec. 31, 2015   298,634          
Increase (Decrease) in Shareholders' Equity              
Stock-based compensation (note 11)   $ 1,039         1,039
Exercise of stock options (note 11)   $ 3,730         $ 3,730
Exercise of stock options (note 11) (in shares)   1,494         1,457
Other-than-temporary impairment on marketable equity securities (note 3)     882       $ 882
Share repurchase (note 10)   $ (582)         (582)
Share repurchase (note 10) (in shares)   (558)          
Shareholder distributions (note 10)   $ (2,986)         (2,986)
Unrealized gain (loss) on available-for-sale securities (note 3)     1,609       1,609
Net (loss) income       21,055     21,055
Balance at Dec. 31, 2016   $ 1,360,345 1,666 (918,972)     443,039
Balance (in shares) at Dec. 31, 2016   299,570          
Increase (Decrease) in Shareholders' Equity              
Stock-based compensation (note 11)   $ 1,311         1,311
Shares issued for cash (note 10 and note 19)   $ 39,397     $ 7,799   39,397
Shares issued for cash (note 10 and note 19) (in shares)   20,700     4,000    
Shares issued in connection with acquisitions (note 10) $ 38,141         $ 38,141  
Shares issued in connection with acquisitions (note 10) (in shares) 12,687            
Exercise of stock options (note 11)   $ 122         $ 122
Exercise of stock options (note 11) (in shares)   94         94
Other-than-temporary impairment on marketable equity securities (note 3)     356       $ 356
Shareholder distributions (note 10)   $ (3,059)         (3,059)
Reclassification of unrealized gain on marketable securities disposed of during the period, net of taxes (note 3)     (840)       (840)
Unrealized gain (loss) on available-for-sale securities (note 3)     1,818       1,818
Net (loss) income       (10,634)     (10,634)
Balance at Dec. 31, 2017   $ 1,447,879 3,000 (929,606)     521,273
Balance (in shares) at Dec. 31, 2017   337,051          
Increase (Decrease) in Shareholders' Equity              
Warrants issued in connection with the equity issuance (note 10)   $ 3,823         3,823
Balance at Dec. 31, 2017   1,447,879   (926,606)     521,273
Increase (Decrease) in Shareholders' Equity              
Stock-based compensation (note 11)   269         269
Shares issued for cash (note 10 and note 19)   $ 918     $ 11,145   918
Shares issued for cash (note 10 and note 19) (in shares)   515     6,634    
Shares issued in connection with acquisitions (note 10)   $ 391         391
Shares issued in connection with acquisitions (note 10) (in shares)   178          
Exercise of stock options (note 11)   $ 192         $ 192
Exercise of stock options (note 11) (in shares)   182         171
Share repurchase (note 10) (in shares)             0
Shareholder distributions (note 10)   $ (3,372)         $ (3,372)
Net (loss) income       (44,870)     (44,870)
Balance at Dec. 31, 2018   $ 1,457,422   (971,476)     $ 485,946
Balance (in shares) at Dec. 31, 2018   344,560          
Increase (Decrease) in Shareholders' Equity              
Adoption of ASU 2016-01 (note 2 and note 3) | Accounting Standards Update 2016-01     $ (3,000) $ 3,000